{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:57:01Z","timestamp":1780059421595,"version":"3.54.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"DOI":"10.7759\/cureus.106695","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:28:19Z","timestamp":1775723299000},"source":"Crossref","is-referenced-by-count":1,"title":["Herpes Zoster Following Chemo-Immunotherapy With Pembrolizumab in Metastatic Non-small Cell Lung Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Andy","family":"Kouanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamadoun","family":"Traor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choukri","family":"Elm'hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Tanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader N","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, et al.. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020, 383:640-9. 10.1056\/NEJMoa1916623","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi L","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, et al.. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018, 378:2078-92. 10.1056\/NEJMoa1801005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01597 frontiersin +1","article-title":"PD-1\/PD-L1 blockade: have we found the key to unleash the antitumor immune response?","volume":"8","author":"Xu-Monette ZY","year":"2017","unstructured":"Xu-Monette ZY, Zhang M, Li J, et al.. PD-1\/PD-L1 blockade: have we found the key to unleash the antitumor immune response?. Front Immunol. 2017, 8:1597. 10.3389\/fimmu.2017.01597 frontiersin +1","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1051\/medsci\/20163204013","article-title":"[The interplay of immunotherapy and chemotherapy, a novel approach]","volume":"32","author":"Hanoteau A","year":"2016","unstructured":"Hanoteau A, Henin C, Moser M. [The interplay of immunotherapy and chemotherapy, a novel approach]. Med Sci (Paris). 2016, 32:353-61. 10.1051\/medsci\/20163204013","journal-title":"Med Sci (Paris)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/v10110609","article-title":"Clinical features of varicella-zoster virus infection","volume":"10","author":"Kennedy PG","year":"2018","unstructured":"Kennedy PG, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018, 10:609. 10.3390\/v10110609","journal-title":"Viruses"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0815","article-title":"The epidemiology of herpes zoster in patients with newly diagnosed cancer","volume":"22","author":"Habel LA","year":"2013","unstructured":"Habel LA, Ray GT, Silverberg MJ, et al.. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013, 22:82-90. 10.1158\/1055-9965.EPI-12-0815","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0810-6","article-title":"The epidemiology of herpes zoster and its complications in Medicare cancer patients","volume":"15","author":"Yenikomshian MA","year":"2015","unstructured":"Yenikomshian MA, Guignard AP, Haguinet F, et al.. The epidemiology of herpes zoster and its complications in Medicare cancer patients. BMC Infect Dis. 2015, 15:106. 10.1186\/s12879-015-0810-6","journal-title":"BMC Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy626","article-title":"Risk of herpes zoster in cancer patients and the promise of new vaccines","volume":"220","author":"Kawai K","year":"2019","unstructured":"Kawai K, Yawn BP. Risk of herpes zoster in cancer patients and the promise of new vaccines. J Infect Dis. 2019, 220:1-2. 10.1093\/infdis\/jiy626","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-21-2764","article-title":"Herpes zoster in lung cancer patients treated with PD-1\/PD-L1 inhibitors","volume":"11","author":"Taoka M","year":"2022","unstructured":"Taoka M, Ochi N, Yamane H, et al.. Herpes zoster in lung cancer patients treated with PD-1\/PD-L1 inhibitors. Transl Cancer Res. 2022, 11:456-66. 10.21037\/tcr-21-2764","journal-title":"Transl Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0333","article-title":"Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors","volume":"14","author":"Serra F","year":"2022","unstructured":"Serra F, Cassaniti I, Lilleri D, Pedrazzoli P, Baldanti F, Lasagna A. Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors. Immunotherapy. 2022, 14:389-93. 10.2217\/imt-2021-0333","journal-title":"Immunotherapy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw539","article-title":"The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma","volume":"63","author":"Del Castillo M","year":"2016","unstructured":"Del Castillo M, Romero FA, Arg\u00fcello E, Kyi C, Postow MA, Redelman-Sidi G. The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma. Clin Infect Dis. 2016, 63:1490-3. 10.1093\/cid\/ciw539","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3532","article-title":"Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy","volume":"9","author":"Kanjanapan Y","year":"2020","unstructured":"Kanjanapan Y, Yip D. Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy. Cancer Med. 2020, 9:9027-35. 10.1002\/cam4.3532","journal-title":"Cancer Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217260","article-title":"Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy","volume":"77","author":"Morelli T","year":"2022","unstructured":"Morelli T, Fujita K, Redelman-Sidi G, Elkington PT. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. Thorax. 2022, 77:304-11. 10.1136\/thoraxjnl-2021-217260","journal-title":"Thorax"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32832d7aff","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients","volume":"22","author":"Sun HY","year":"2009","unstructured":"Sun HY, Singh N. Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2009, 22:394-402. 10.1097\/QCO.0b013e32832d7aff","journal-title":"Curr Opin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13957","article-title":"European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment","volume":"31","author":"Werner RN","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi\u0107 B, et al.. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017, 31:20-9. 10.1111\/jdv.13957","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/481699-herpes-zoster-following-chemo-immunotherapy-with-pembrolizumab-in-metastatic-non-small-cell-lung-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:28:22Z","timestamp":1775723302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/481699-herpes-zoster-following-chemo-immunotherapy-with-pembrolizumab-in-metastatic-non-small-cell-lung-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.106695","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}